Skip to content

Sticky Bone and Repeated Injectable PRF (iPRF) Application in Management of Periodontal Intrabony Defects

Sticky Bone and Repeated Injectable PRF Application in Management of Periodontal Intrabony Defects (Randomized Clinical Trial)

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05211362
Acronym
IPRF
Enrollment
32
Registered
2022-01-27
Start date
2022-04-16
Completion date
2022-11-22
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iPRF, Periodontal Defect, Sticky Bone

Keywords

iPRF, sticky bone graft

Brief summary

One of the main objectives of periodontal therapy is the regeneration of the tooth's supporting periodontal tissue to its original levels. The healing after non-surgical and conventional surgical methods is histologically characterized by a long junctional epithelium along the root surfaces. Therefore, reconstructive techniques are required. Although complete periodontal regeneration is unpredictable with any regenerative therapy currently used, so the objective of our trial is to get complete periodontal regeneration by using Sticky Bone and Repeated Injectable PRF (iPRF) in Management of Periodontal Intrabony Defects.

Interventions

BIOLOGICALSticky Bone and Repeated Injectable PRF (iPRF)

The surgical treatment phase was initiated only if the subjects had a full-mouth dental plaque score of less than one and a test site plaque score of 0. Following mucoperiosteal flap reflection for one tooth on either side of the defect, all granulation tissue was removed from the defects by means of Gracey 7/8 metal curettes, and root surfaces were scaled and planed using hand and ultrasonic instruments, then the defect was filled with xenograft mixed with IPRF, Finally, the flap was replaced and closed with crossed horizontal and vertical internal mattress sutures.

BIOLOGICALbone substitute

The surgical treatment phase was initiated only if the subjects had a full-mouth dental plaque score of less than one and a test site plaque score of 0. Following mucoperiosteal flap reflection for one tooth on either side of the defect, all granulation tissue was removed from the defects by means of Gracey 7/8 metal curettes, and root surfaces were scaled and planed using hand and ultrasonic instruments, bone graft substitute was heavily condensed into the intra bony defects. The flap was replaced and closed with crossed horizontal and vertical internal mattress sutures.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 48 Years
Healthy volunteers
Yes

Inclusion criteria

* No systemic diseases which could influence the outcome of therapy. * Good compliance with plaque control instructions following initial therapy. * Teeth involved were all vital with no mobility. * Each subject contributed a single predominately 2 or 3-wall intrabony interproximal defect around premolar or molar teeth without furcation involvement * Selected intrabony defects (IBD) measured from the alveolar crest to the defect base in diagnostic periapical radiographs of ≥ 3 mm, the width of ≥ 3 mm at its most coronal part, with no cratering that involve both mesial and distal surfaces of adjacent teeth. * Selected probing depth (PD) ≥ 6 mm and clinical attachment loss (CAL) ≥ 4 mm at the site of intraosseous defects four weeks following initial cause-related therapy. * Availability for the follow-up and maintenance program; 8) absence of periodontal treatment during the previous year.

Exclusion criteria

• Pregnant females.

Design outcomes

Primary

MeasureTime frameDescription
change in clinical attachment levelbaseline, 3, and 6 monthschange in clinical attachment level

Secondary

MeasureTime frameDescription
change in interseptal bone widthbaseline, 3, and 6 monthschange in interseptal bone width

Countries

Egypt

Contacts

Primary ContactAl Azhar University University
Azhar@azhar.eun.eg0020222628346
Backup Contactmahmoud eldestawy, associted profissor
mahmoudeldestawy.209@azhar.edu.eg00201225864104

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026